Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient is able to provide written informed consent before beginning any study related procedures~* Patient has a documented clinical diagnosis of major depressive disorder~* Patient is able to understand and comply with the requirements of the study, as judged by a study investigator~Exclusion Criteria:~* Patients with a history of non-compliance as judged by the study investigator~* Patients with a known lack of response to previous treatment with quetiapine~* Patients who have participated in a clinical trial within 4 weeks of randomization

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).